Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 230,000 | reported | 30 Jan 2026 | tx 20+608,859−117,718 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 230,000 | 5.71 USD | deriv |
| 22 Jan 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 115,000 | 4.37 USD | deriv |
| 23 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 857 | 3.72 USD | |
| 20 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 35,756 | 10.04 USD | |
| 20 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 35,756 | 3.72 USD | |
| 23 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 857 | 10.17 USD | |
| 23 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 857 | 0.00 USD | deriv |
| 20 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 35,756 | 0.00 USD | deriv |
| 18 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 11,574 | 3.72 USD | |
| 18 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 11,574 | 10.05 USD | |
| 18 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 11,574 | 0.00 USD | deriv |
| 16 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 400 | 3.72 USD | |
| 17 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 10,272 | 3.72 USD | |
| 16 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 400 | 10.00 USD | |
| 17 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 10,272 | 10.04 USD | |
| 16 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 400 | 0.00 USD | deriv |
| 17 Sept 2024 | EXERCISE | Foghorn Therapeutics Inc. | 10,272 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | Foghorn Therapeutics Inc. | 90,000 | 3.06 USD | deriv |
| 26 Jan 2023 | GRANT_AWARD | Foghorn Therapeutics Inc. | 65,000 | 0.00 USD | deriv |
| 01 Aug 2022 | GRANT_AWARD | Foghorn Therapeutics Inc. | 50,000 | 0.00 USD | deriv |